Skip to main content

Featured

Wall Street Rallies as Trade Hopes and Tech Surge Lift Futures to New Heights

U.S. stock futures surged Monday morning, with the S&P 500 and Nasdaq 100 climbing to record highs, buoyed by renewed optimism over international trade negotiations and a tech-led rally. The momentum followed Canada’s decision to scrap its digital services tax targeting American tech giants—an unexpected move that helped thaw stalled trade talks with the U.S. Shares of major technology firms including Amazon, Meta, Alphabet, and Apple rose between 0.6% and 1.7% in premarket trading. The broader market also found support from expectations of deeper interest rate cuts by the Federal Reserve, fueled by soft economic data and speculation that President Donald Trump may replace Fed Chair Jerome Powell with a more dovish successor. As of early trading, S&P 500 e-minis were up 0.39%, Nasdaq 100 futures gained 0.6%, and Dow futures added 0.46%. Despite the record-setting highs, analysts note that the major indexes are still on track for their weakest first-half performance since 2022. ...

article

Federal Government Boosts Vaccine Injury Compensation Fund with Additional $36 Million

 

The Canadian federal government has recently allocated an additional $36.4 million to the Vaccine Injury Compensation Fund, a program designed to support individuals who have experienced serious injuries or fatalities related to vaccines since the end of 2020. Here are the key details:

  1. Purpose of the Fund:

    • The program was established shortly after COVID-19 vaccines became available to the public.
    • It provides financial compensation to people who suffered adverse effects due to Health Canada-approved vaccines.
    • The goal is to assist those who were seriously impacted by vaccination.
  2. Funding and Administration:

    • The Liberal government initially earmarked $75 million for the first five years of the program.
    • A private firm called OXARO manages the program and disburses valid claims originating outside of Quebec.
    • To date, OXARO has received $56.2 million from Ottawa and has paid out $11.2 million in compensation.
    • Quebec has its own vaccine injury compensation program, which received $7.75 million when the federal program launched.
  3. Recent Funding Boost:

    • As part of the federal budget, the government allocated an additional $36 million to OXARO and Quebec.
    • This funding covers the next two years of the program.
    • The Public Health Agency of Canada contracted OXARO to ensure an impartial claims process.
  4. Eligibility and Claims:

    • The program covers injuries and deaths associated with vaccines approved for any illness.
    • Eligibility criteria include severe, life-threatening, or life-altering injuries resulting in disability, incapacity, birth defects, or death.
    • The available statistics do not specify which vaccines were involved.
  5. Rare Adverse Reactions:

    • Serious adverse reactions to vaccines are extremely rare (affecting less than one in a million people).
    • Nevertheless, the government recognizes its duty to provide support when such reactions occur.
    • Ottawa has also made COVID-19 vaccination mandatory for travel and federal public service employment.

In summary, the additional funding aims to ensure that those affected by vaccine-related injuries receive appropriate compensation while maintaining an impartial claims process. The program underscores the importance of vaccine safety and accountability in public health efforts. 


Comments